Celldex Therapeutics, Inc.
CLDXNASDAQHealthcare● Active
$28.56
$-0.06(-0.21%)
Market Cap$1.9B
P/E Ratio—
52W High$35.79
52W Low$19.52
Celldex Therapeutics, Inc.（CLDX）· 现金流量表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · CLDX · 截至 2026-06-10
财务报表
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | ($258.76M) | ($157.86M) | ($141.43M) | ($112.33M) | ($70.51M) |
| Depreciation & Amort. | ($2.48M) | $3.18M | $3.01M | $1.40M | $3.07M |
| Stock-Based Comp. | $36.22M | $34.24M | $23.89M | $0.00M | $8.95M |
| Change in Working Capital | $14.06M | ($21.60M) | $13.46M | ($3.90M) | ($1.05M) |
| Net Cash from Operations | ($210.94M) | ($157.78M) | ($107.29M) | ($103.73M) | ($60.91M) |
| Investing Activities | |||||
| Capital Expenditure | ($2.71M) | ($1.92M) | ($1.82M) | ($1.83M) | ($1.25M) |
| Purchases of Investments | ($384.50M) | ($789.92M) | ($424.56M) | ($188.97M) | ($389.88M) |
| Sales of Investments | $596.29M | $501.71M | $320.60M | $280.67M | $174.95M |
| Net Cash from Investing | $209.07M | ($290.13M) | ($105.78M) | $89.94M | ($216.16M) |
| Financing Activities | |||||
| Common Stock Repurchased | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Dividends Paid | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Debt Issued / Repaid | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Cash from Financing | $2.39M | $441.45M | $218.46M | $4.08M | $272.37M |
| Free Cash Flow | |||||
| Free Cash Flow | ($213.66M) | ($159.70M) | ($109.11M) | ($105.56M) | ($62.16M) |
| FCF Margin %(computed) | — | — | — | — | — |
数据来源：Financial Modeling Prep · 最后更新：2026-06-10 · USD · M
深入了解Celldex Therapeutics, Inc.
关于Celldex Therapeutics, Inc.（CLDX）现金流量表
Celldex Therapeutics, Inc. 2025财年经营活动现金流($0.21B)，自由现金流($0.21B)（FCF利润率-14243.93%），资本支出($0.00B)。
常见问题
CLDX · 4 问Celldex Therapeutics, Inc. 2025财年自由现金流($0.21B)，同比down33.8%。
CLDX free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10